Auris Nasus Larynx provides the opportunity for rapid, carefully reviewed publications concerning the fundamental
and clinical aspects of otorhinolaryngology and related fields. This includes otology, neurotology, bronchoesophagology, laryngology,
rhinology, allergology, head and neck medicine and oncologic surgery, maxillofacial and plastic surgery, audiology, speech science and
communication disorders.
Types of papers
Original papers, short communications and original case reports can be submitted.
Reviews on recent developments are invited regularly and Letters to the Editor commenting on papers or any aspect of the Journal are
welcomed.
Original papers should report the results of original research, and the material should not have been previously
published elsewhere, except in preliminary form. Manuscripts should be as concise and to the point as possible. Please condense your
manuscript as much as possible. It is recommended that papers should in general not exceed 10 printed pages.
Short communications
are brief and contain significant new results. Recommended size is a maximum of 4 printed pages (6-8 double-spaced typed pages) including
figures and tables. Short Communications should be concisely but adequately referenced.
Case reports should describe truly
unique and/or educationally valuable cases, which provide benefits for future patients. Text should be limited to 1800 words (6 double-spaced
typewritten pages) including an abstract, with no more than 15 references and a maximum of 4 figures/tables. An abstract for case reports
should no exceed 200 words and should not have a structured format.
Submission and peer review of all papers is now conducted entirely online using the dedicated site at http://ees.elsevier.com/anl
Authors are required to register upon using the system for the first time. Authors are guided stepwise through the entire process, and
are kept abreast of the progress of their paper at each stage.
The system creates a PDF version of the submitted manuscript for peer
review, revision and proofing. All correspondence, including the Editor's decision and request for revisions, is conducted by e-mail.
Further information and support
Authors requesting further information on online submission are strongly encouraged to view
an online tutorial, at http://ees.elsevier.com/anl. A comprehensive Author Support service is also available to answer additional
enquiries at authorsupport@elsevier.com.
Global telephone support is available for e-submission 24/7:
For The Americas: +1 888 834 7287 (toll-free for US & Canadian customers)
For Asia & Pacific: +81 3 5561 5032
For Europe & rest of the world: +353 61 709190
Submission of manuscripts: Copyright
Submission of an article is understood to imply
that the article is original and is not being considered for publication elsewhere. Upon acceptance of the article by the journal, the
author(s) will be asked to transfer the copyright of the article to the publisher. This transfer will ensure the widest possible dissemination
of information.
Multiple authorship
On submission, all authors of the paper listed should sign a letter in which they state
that they all have participated sufficiently in the conception and design of the work, in the analysis of the data and in writing the
manuscript to take public responsibility for it.
Ethical standards
Human subject experiments or the usage of human materials
(such as tissues) should be in accordance with the ethical standards of a responsible committee at the institute where the research is
carried out and with the Helsinki Declaration. Animal studies should be carried out within recognised guidelines for the care of laboratory
animals.
Preparation of manuscripts
Preparing your manuscript
Authors are asked to bear in mind the following
additional points before entering the submission process.
Ensure that the letter "l" and digit "1" (also letter "O" and digit
"0") have been used properly, and structure your article (tabs, indents, etc.) consistently. Characters not available on your word processor
(e.g. Greek letters, mathematical symbols, etc.) should not be left open but indicated by a unique code (e.g. gralpha, @, #, etc., for
the Greek letter alpha). Such codes should be used consistently throughout the entire text.
Please make a list of such codes and
provide a key. Do not allow your word processor to introduce word splits at the end of lines and do not use justified right margins.
Manuscripts should be written in English. Authors whose native language is not English are strongly advised to have their manuscripts
checked by an English-speaking colleague prior to submission.
Format and Structure
Most text formats can be accommodated,
but Microsoft Word is preferable. Manuscripts should in general be divided into the following components: title, authors' names and affiliations,
abstract, keywords, text (introduction, materials and methods, results, discussion, conclusion, acknowledgments), references, tables,
figure legends, figures. Number pages consecutively.
The title page should include (1) a concise but informative title, (2) authors'
names, affiliations and full postal addresses, (3) name, telephone number and e-mail address of the author handling correspondence and
proofs.
Abstract
An abstract of your manuscript summarizing the content, at a maximum of 400 words, should be provided
as a separate submission item. It should be informative, not merely descriptive, and it must be composed by four divisions: (1) Objective
should concisely describe the hypothesis, problem and/or purpose of the study; (2) Methods should include basic procedures and
materials, and observational and analytical methods; (3) Results should describe major findings and statistical significance,
if possible by all means; and (4) Conclusion must very clearly and concisely state the principal conclusion(s) of the study.
Reviews and Case reports need not follow these instructions. Abstracts for Case reports should not exceed 200 words.
Keywords
3-6 keywords (indexing terms) should be supplied. Full instructions are provided when submitting your article online.
Figures
Figures of good quality should be submitted online as a separate file.
Illustrations should be numbered with Arabic numerals according
to their sequence in the text. References should be made in the text to each illustration.
Illustrations should be designed with the
format of the page of the journal in mind. Illustrations and lettering should be of such a size as to allow a photographic reduction
of 50% without becoming illegible. Explanations should preferably be given in the typewritten legend. Drawn text in the illustrations
should be kept to a minimum.
If scales are required, use bar scales on the illustration itself instead of numerical magnification
factors.
Each illustration should have a legend. The legends to all illustrations should be typed together on a separate sheet at
the end of the manuscript.
Colour illustrations can only be included, if the cost of reproduction is paid for by the author or a sponsor.
Permission to reproduce illustrations should always be obtained before submission and details included with the captions.
For detailed
instructions on the preparation of electronic artwork, consult Elsevier's Author Gateway at http://authors.elsevier.com.
Tables
Tables should be submitted online as a separate file, bear a concise title, and be numbered with Arabic numerals. Tables
should be cited in the text. Column headings should be brief, but sufficiently explanatory. Standard abbreviations of units of measurement
should be added between parentheses. Vertical lines should not be used to separate columns.
References
1. All publications
cited in the text should be presented in a list of references following the text of the manuscript. The manuscript should be carefully
checked to ensure that the spelling of authors' names are exactly the same in the text and in the list of references. Authors are responsible
for the accuracy and completeness of their references and for correct text citation.
2. References should be numbered consecutively
in the order in which they are first mentioned. In the text they should be cited with Arabic numerals between square brackets. For listing
references, follow the JAMA style, abbreviating names of journals according to Index Medicus. List all authors/editors but if
there are more than six, list the first six plus et al.
Examples:
[1] Froehlich P, Seid AB, Morgon A. Contrasting strategic
approaches to the management of subglottic hemangiomas. Int J Pediatr Otorhinolaryngol 1996;36:137-46.
[2] Marcus R, Couston AM, Water-soluble
vitamins: the vitamin B complex and ascorbic acid. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman's The Pharmacological
Basis of Therapeutics. 8th ed., New York, NY: Pergamon Press. 1990;1530-52.
3. This journal should be cited as Auris Nasus Larynx.
4. Manuscripts accepted for publication not yet published should be referred to as "in press." Manuscripts submitted but not yet accepted
should be referred to as "unpublished observation."
Proofs
One set of proofs will be sent to the corresponding author as
given on the title page of the manuscript. Only typesetters' errors may be corrected; no changes in or additions to, the edited manuscript
will be allowed.
Offprints
Fifty offprints of each article will be supplied free of charge. Additional offprints can be
ordered by the authors. An order form containing price quotations will be sent to the corresponding author.
All questions arising
after acceptance of the manuscript, especially those relating to proofs, should be directed to: Editorial Dept., Elsevier Scientific
Publishers Ireland Ltd., Elsevier House, Brookvale Plaza, East Park, Shannon, Co. Clare, Ireland, Tel: +353-61-709652, Fax: +353-61-709110.
